$ADMS Adamas Pharmaceuticals Inc Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adamas Pharmaceuticals Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adamas Pharmaceuticals Inc. Insider overview, share value development, latest insider transactions and email notifications about new events in Adamas Pharmaceuticals Inc for free.
IRS Number: 421560076
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ADMS
Company Address: 1900 POWELL ST., SUITE 1000 EMERYVILLE 94608
Former name: NeuroMolecular Pharmaceuticals Inc, date of change: 2005-05-24
Market Capitalization: $364.02M
Prev close: $16.16
Average Daily Volume: 154,068
Days Low: $15.93
Year Low: $12.02
Year High: $19.50
Adamas Pharmaceuticals Inc Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2021 | ADMS | Adamas Pharmaceuti ... | Shreedhar Vijay | Chief Commercial Of ... | Sell | S | 5.16 | 6,200 | 31,983 | 165,735 | 171.9 K to 165.7 K (-3.61 %) |
| Jun 08 2021 | ADMS | Adamas Pharmaceuti ... | DEMSKI MARTHA J | Director | Sell | S | 5.17 | 2,000 | 10,340 | 8,000 | 10 K to 8 K (-20.00 %) |
| Jun 04 2021 | ADMS | Adamas Pharmaceuti ... | Papapetropoulos Spyridon | Director | Option Exercise | A | 5.21 | 10,000 | 52,100 | 10,000 | |
| Jun 04 2021 | ADMS | Adamas Pharmaceuti ... | Papapetropoulos Spyridon | Director | Grant | A | 0.00 | 5,000 | 0 | 20,975 | 16 K to 21 K (+31.30 %) |
| Jun 04 2021 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Option Exercise | A | 5.21 | 10,000 | 52,100 | 10,000 | |
| Jun 04 2021 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Grant | A | 0.00 | 5,000 | 0 | 115,153 | 110.2 K to 115.2 K (+4.54 %) |
| Jun 04 2021 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Option Exercise | A | 5.21 | 10,000 | 52,100 | 10,000 | |
| Jun 04 2021 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
| Mar 23 2021 | ADMS | Adamas Pharmaceuti ... | Shreedhar Vijay | Chief Commercial Of ... | Sell | S | 5.50 | 1,051 | 5,781 | 169,435 | 170.5 K to 169.4 K (-0.62 %) |
| Mar 23 2021 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Sell | S | 5.48 | 2,422 | 13,273 | 145,017 | 147.4 K to 145 K (-1.64 %) |
| Mar 16 2021 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Option Exercise | M | 0.67 | 48,000 | 31,920 | 0 | |
| Mar 16 2021 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Buy | M | 0.67 | 48,000 | 31,920 | 110,153 | 62.2 K to 110.2 K (+77.23 %) |
| Mar 16 2021 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | M | 0.67 | 192,000 | 127,680 | 0 | |
| Mar 16 2021 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Buy | M | 0.67 | 192,000 | 127,680 | 197,000 | 5 K to 197 K (+3,840.00 %) |
| Mar 15 2021 | ADMS | Adamas Pharmaceuti ... | Papapetropoulos Spyridon | Director | Buy | P | 5.06 | 5,975 | 30,234 | 15,975 | 10 K to 16 K (+59.75 %) |